Fraud Blocker Peptide Research Library | Licensed Peptides
2 for 1 sale You pick the free one Any vial, any size. NO CODE, NO LIMITS. Extended sale ends in 3d 21h 08m 46s

Need help? Call Or Text us, and a team member will be happy to assist you. +1 (855) 322-2214

The Licensed Peptides research library is written and maintained by the Licensed Peptides research team. Articles summarise the published in-vitro and preclinical literature on the compounds Licensed Peptides supplies for laboratory research. They are written to a research-use-only standard: no dosing guidance, no human-use claims, and factual statements traced to the study they come from. Every article is reviewed for accuracy against the cited studies by Samuel Sarmiento, MD, MPH, MBA.

More about who writes and reviews this library

Articles by Licensed Peptides

  • ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

2010, 2025

MK-677 (Ibutamoren): Research Overview

By |10/20/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction MK-677, also referred to as Ibutamoren, Oratrope, or Crescendo, is a selective agonist of the ghrelin receptor, functioning...

1910, 2025

Thymosin Beta-4 in Neural Repair and Recovery

By |10/19/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction Neurological injury remains one of the most complex challenges in clinical medicine. Despite decades of intensive research and...

1910, 2025

GHK-Cu and Thymosin Beta-4: Research on Hair-Follicle Biology

By |10/19/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Background Androgenic alopecia, often referred to as male-pattern hair loss, is the most prevalent cause of hair thinning in...

1910, 2025

Cerebrolysin in Neurological Research: A Review of Published Findings

By |10/19/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Cerebrolysin is a porcine-derived compound composed of low molecular weight peptides and free amino acids with demonstrated neurotrophic and...

1810, 2025

Cerebrolysin in Vascular Dementia Research

By |10/18/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Overview of Vascular Dementia Vascular dementia (VaD) is recognized as the second most frequent form of dementia following Alzheimer’s...

Stay Ahead of the Curve

Get exclusive updates on events, promotions, and special offers.

You cannot copy content of this page